Clinical Trial

Improving Survivorship for Critically Ill Patients Aged 65 and Over

Study acronym: IMPROVE-65
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
IMPROVE-65 is a randomised control trial designed specifically for people aged over 65 who have survived critical illness. It aims to support patients and general practitioners by providing timely, personalised information to help them work together to make informed goals and decisions about their care after hospital discharge. The aim of the study is to improve recovery and avoid preventable hospital readmissions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-09.
Trial Details
NCT Number NCT07175961
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Conditions Critical Illness, Recovery Outcomes, Care Coordination
Enrollment 300 participants
Start Date 2025-11
Primary Completion 2027-11 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2025-09-19